RYHIX Rydex Health Care Inv Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), Gilead Sciences (NASDAQ:GILD).

The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Health Care Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Health Care Companies that have small to mid-sized capitalizations. The fund also may purchase American Depositary Receipts ("ADRs") to gain exposure to foreign Health Care Companies and U.S. government securities.

The average market capitalization across the Rydex Health Care Inv MF is 353.73B. The market cap for tickers in the group ranges from 138.91B to 1.12T. LLY holds the highest valuation in this group at 1.12T. The lowest valued company is VRTX at 138.91B.

The average weekly volume growth across all stocks in the Rydex Health Care Inv MF was 59%. For the same stocks of the MF, the average monthly volume growth was -2% and the average quarterly volume growth was -13%